幸福藍海(300528.SZ):截至2023年12月31日,幸福藍海院線旗下影城累計591家、3533張銀幕
格隆匯5月20日丨幸福藍海(300528.SZ)在投資者互動平台表示,截至2023年12月31日,幸福藍海院線旗下影城累計591家、3533張銀幕。其中,院線加盟影城共計460家、2671張銀幕;自有直營影城共計131家、862張銀幕,幸福藍海院線的全國排名升至第六,江蘇省內市場連續九年穩居第一。幸福藍海在影城終端佈局方面堅持“深耕江蘇、兩沿(沿海、沿江)發展、輻射全國”的發展戰略,積極推進全國重點票倉城市影院建設,進一步提升幸福藍海國際影城的市場影響力和品牌美譽度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.